Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers
Be clear about what youve tried
What Should You Consider: Safety: Compounded medications are not FDA-approved
These results translated to significant proportions of participants achieving clinically meaningful weight loss: 5% or More Weight Reduction: 92% (4 mg), 100% (8 mg), 100% (12 mg), and 27% (placebo) 10% or More Weight Reduction: 75% (4 mg), 91% (8 mg), 93% (12 mg), and 9% (placebo) 15% or More Weight Reduction: 60% (4 mg), 75% (8 mg), 83% (12 mg), and 2% (placebo) These data underscore retatrutides potential to deliver unprecedented weight loss in a significant portion of individuals with obesity
Demand for GLP-1 receptor agonists is expected to grow at an 11.7% CAGR between 2026 and 2036
Insurance companies vary in their coverage of these medications
US$ 29.40
US$ 23.16
US$ 21.25
US$ 22.61
US$ 29.14
